cigna coverage for glp 1 will stop covering GLP-1 weight-loss drugs including Wegovy and Zepbound in its employee health plan effective July 1, according to Reuters Cigna prior authorization for Ozempic,
Description
Understanding the Growing Interest in GLP-1 Medications Are you a breastfeeding mother wondering about taking weight loss medications like semaglutide (Ozempic, Wegovy, or Rybelsus) or tirzepatide (Mounjaro or Zepbound)
Reader insights There are no comments for this story Be the first to respond and start the conversation.
doi: 10.1111/jdi.12275 75 NauckMRizzoMJohnsonABosch-TrabergHMadsenJCariouB
that rapid weight loss may affect bone density, especially in populations already vulnerable to bone loss
Understanding your gut ecosystem allows for targeted interventions that support continued success beyond medication
A legitimate semaglutide prescription and physician oversight before and during semaglutide treatment is vital to ensure safety
